Understanding and Alleviating Healthcare System Pressure: A Conceptual Framework

By Staff Writer

February 14, 2024

Introduction:

The COVID-19 pandemic has highlighted the devastating effects of resource scarcity in healthcare systems. This emphasises the need to understand and ease Healthcare System Pressure (HCSP). While there’s no official HCSP definition, the Office of Health Economics (OHE) has developed and examined a conceptual framework for HCSP. It includes a broad definition and concepts of HCSP, strategies to lessen HCSP, and a system for metric categorisation.

Understanding Healthcare System Pressure:

Long before the COVID-19 pandemic, healthcare systems were feeling the strain. This is evident in the UK, where increasing waiting lists and treatment times are common. Yet, the term ‘pressure’ lacks a clear definition in the healthcare context. When healthcare systems face strain, they behave differently than in normal conditions. This strain could lead to an inability to provide emergency care or delay planned care. Moreover, the quality of care might suffer due to continuous pressure on staff. This can lead to staff burnout and poorer health outcomes for patients.

The Conceptual Framework of HCSP:

The primary exposure of hospital settings to increased patient demand in the event of seasonal diseases or pandemics was the driving force for the decision to concentrate on HCSP in hospital settings. It was the findings of the review that served as the basis for the construction of each individual component of the conceptual framework. They also conducted a ‘proof-of-concept’ exercise utilising expert interviews from Germany, Italy and the UK to test the comprehensiveness and usefulness of this framework, using respiratory syncytial virus (RSV) and Clostridioides difficile (C. difficile) infections as case studies.

Universally Accepted Definition of HCSP:

HCSP can affect different types of resources that can be categorised into ‘staff’ (i.e., labour resources), ‘stuff’ (i.e., durable equipment) and ‘structures’ (physical infrastructure within the hospital). A resource has a usable capacity, which is the amount of capacity available for production in normal circumstances. The usable capacity can be split into utilised capacity, which is actually used for production, and idle capacity, which remains unused. Using the concepts of resources, capacity, and utilisation, HCSP can be described as occurring when the demand determining the utilised capacity of a resource exceeds its usable capacity (Figure 1).

Alleviating HCSP:

Keeping bed occupancy below 85% is crucial for hospitals to operate safely and effectively, as seen in the English National Health System (NHS). This framework identifies two main actions to alleviate HCSP: increasing the usable capacity to accommodate higher demand levels and expanding the usable capacity as a pressure-mitigating action. These actions are linked to the concept of surge capacity, which is predominantly applied within the field of disaster management.

Classifying HCSP Metrics:

The OHE found no consensus on the metrics of HCSP and its opportunity costs. However, for each resource, HCSP can be measured using usable and utilised capacity metrics. Routinely collected key performance indicators (KPIs) in hospital finance, procedures, and staff provide multiple pressure measurement alternatives. Some KPIs directly measure resource utilisation (e.g. bed occupancy and average length of stay), while others indirectly indicate pressure (e.g. staff turnover or waiting times). This can impact quality indicators and outcomes, such as mortality rates.

Conclusion:

The proposed framework may have beneficial and practical applications. We could use the HCSP formulation to evaluate health technologies that reduce pressure on the healthcare system. This evaluation forms part of the health technology assessment (HTA). The goal of HTA is to guide the efficient use of limited healthcare resources. This becomes crucial in high-strain situations like those seen in the NHS, leading to elective surgery cancellations and potential medical care rationing. Traditional HTA approaches may underestimate HCSP-easing health innovations such as vaccinations. This is because of the large elective care backlogs and the high potential cost of delayed treatment.

Reference url

Recent Posts

340B Drug Pricing Lawsuit
      

Lawsuits Challenge 340B Drug Pricing Program: Eli Lilly and J&J vs. HRSA

🤔 How will ongoing legal battles shape the future of the 340B Drug Pricing Program?

Eli Lilly and Johnson & Johnson are challenging HRSA’s proposed rebate models, arguing that their approaches are essential for enhancing transparency and ensuring discounts directly benefit vulnerable patients. This crucial legal dispute highlights the tensions surrounding drug pricing regulations and could profoundly impact how discounts are provided to covered entities.

Dive into the details of these lawsuits and their implications for the pharmaceutical landscape.

#SyenzaNews #pharmaceuticals #healthcarepolicy #innovation #DrugPricing

WHO Investment Round 2023
    

WHO Investment Round: Securing Funding with Transparency Challenges

🌍 How can global health initiatives thrive with increased funding?

The WHO Investment Round is a pivotal initiative striving to secure $7.1 billion for essential health programs from 2025 to 2028. While achieving 53% of this target via diverse donor engagement, transparency in funding remains a challenge. Discover how these efforts can accelerate progress towards universal health coverage and tackle critical health issues like malaria and cervical cancer!

#SyenzaNews #globalhealth #universalhealthcoverage #healthcare #innovation

HPV vaccination South Africa
    

HPV vaccination South Africa: Cervical Cancer Prevention

🌍 How is South Africa leading the charge against cervical cancer?

Since launching its HPV vaccination program, the country has made remarkable strides in protecting future generations. With impressive coverage rates and a focus on at-risk populations, South Africa serves as a global model for effective public health strategies. Discover how this initiative not only combats cervical cancer but also addresses broader health concerns.

#SyenzaNews #HealthTech #GlobalHealth #HealthcareInnovation #CervicalCancer #HPVVaccination

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.